Previously Published to TMC Net’s HealthTech Zone Evariant, which offers an end-to-end CRM solution, has announced it received $42.3M in Series C financing through financial institution, Goldman Sachs, which will be used toward innovations in their current CRM healthcare platform for providers. The company also said it secured both Series A and B leads in Health Enterprise Partners and Lightspeed Venture Partners, who have raised additional funding on behalf of the brand. With over $70M in funding, the startup plans to focus on growth and evolution of their platform, starting with service lines, engineering and customer success teams. Recently opening a fourth office in Austin, this capital will allow Evariant…